$IART Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of $0.59 up 9.26% YoY
• Reported revenue of $411.18M up 2.27% YoY
• Integra LifeSciences expects Q4 2026 revenue of $413M to $433M and adjusted diluted EPS of $0.61 to $0.71; FY2026 revenue of $1.63B to $1.65B and adjusted EPS of $2.30 to $2.40.